Advertisement

Document › Details
908 Devices, Inc.. (6/2/15). "Press Release: 908 Devices Awarded $11.5M Contract from the Defense Threat Reduction Agency (DTRA)". Boston, MA.
This contract fuels development of advanced GC-HPMS devices, providing broader chemical detection capability for military personnel
908 Devices, a pioneer of purpose-built devices for chemical analysis, today announced it was awarded a contract valued up to $11.5 million by the Defense Threat Reduction Agency (DTRA) for the development of advanced chemical detection devices powered by High-Pressure Mass SpectrometryTM (HPMS) technology.
Under this development program, 908 Devices will integrate Gas Chromatography (GC) with its core HPMS technology creating a compact, lightweight chemical detection device that will provide warfighters with broader and more advanced analysis capabilities downrange.
DTRA fuels next-generation technology development programs with the goal of providing the Department of Defense (DoD) the means for countering threats posed by weapons of mass destruction and Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE) threats. These developments support a range of Joint Program Executive Office (JPEO) acquisition programs for Chemical and Biological Defense including the Next Generation Chemical Detector (NGCD) Program managed by the JPEO’s Joint Project Manager for Nuclear, Biological, and Chemical Contamination Avoidance.
“We are honored to receive this contract from DTRA and support their mission to better equip our U.S. warfighters with improved threat detection capabilities,” said Dr. Kevin Knopp, President and CEO, 908 Devices. “Today’s responders are faced with a wider array of threats than ever before, and as the mission expands so must the toolkit. We believe the development of new product variants based on our core HPMS technology platform will play a key role in the future of threat detection and strengthen mission support.”
Under this program, 908 Devices will subcontract with the University of North Carolina at Chapel Hill (UNC-CH) along with other commercial entities and national laboratories. Professor J. Michael Ramsey, Goldby Distinguished Professor of Chemistry at UNC-CH and collaborators initially developed HPMS technology under funding from the Defense Advanced Research Agency (DARPA), Department of Energy (DOE) and DTRA. This platform has become the backbone behind 908 Devices’ product line, including the flagship product, M908, launched in 2014. M908 is a handheld survey tool for priority threat detection and is expanding first responder capabilities around the globe.
The addition of GC separation to the core HPMS platform will be a significant milestone that brings enhanced analytical capabilities to a diverse range of markets in addition to the company’s core safety and security customers.
About 908 Devices
908 Devices, an innovator in point-of-need chemical analysis, offers products from rugged, handheld chemical detection tools to compact, tiny footprint analyzers for researchers, serving a range of industries including safety and security, energy, petrochemical, and life sciences. 908 Devices is headquartered in the heart of Boston, where they research, design and manufacture innovative products based on High-Pressure Mass SpectrometryTM (HPMS).
To find out more about HPMS and M908 visit http://www.908devices.com or email info@908devices.com. You can also follow us on Twitter at @908devices and on LinkedIn at http://www.linkedin.com/908Devices.
Contacts
For 908 Devices
Media Contact:
Nikki Festa/ Alexandra Henry, +1 617-502-4300
908Devices@pancomm.com
or
Corporate Contact:
Alyssa Ludvino, +1 978-427-1026
alyssa@908devices.com
Record changed: 2016-06-07 |
Advertisement
![Picture [iito] No Tracking 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-tracking.jpg)
More documents for 908 Devices Inc. (Nasdaq: MASS)
- [1] 908 Devices, Inc.. (12/18/20). "Press Release: 908 Devices Announces Pricing of Initial Public Offering"....
- [2] 908 Devices, Inc.. (8/12/19). "Press Release: 908 Devices Launches the Rebel, the First At-line Spent Cell Media Analyzer for Bioprocess Labs". Boston, MA....
- [3] 908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA....
- [4] 908 Devices, Inc.. (6/14/19). "Press Release: 908 Devices Addresses Emerging Novichok Nerve Agent Threat, Expands Capabilities for MX908 Chemical Detection Device". Boston, MA....
- [5] 908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA....
- [6] 908 Devices, Inc.. (4/29/19). "Press Release: 908 Devices Secures $17.5 Million in Growth Funding". Boston, MA....
- [7] 908 Devices, Inc.. (1/9/19). "Press Release: 908 Devices’ High-Pressure Mass Spectrometry (HPMS) Technology to Power Next-Generation Advanced Chemical Threat Detector for U.S. Department of Defense". Boston, MA....
- [8] 908 Devices, Inc.. (10/23/18). "Press Release: 908 Devices' MX908 Out-designs Designer Drugs. Unlocks Detection Capabilities for more than 2000 Fentanyl Variants". Boston, MA....
- [9] 908 Devices, Inc.. (7/10/18). "Press Release: 908 Devices and Hangzhou Just Biotherapeutics Announce Joint Innovation Partnership. ZipChip Platform Makes Market Entry in China". Boston, MA....
- [10] 908 Devices, Inc.. (6/4/18). "Press Release: 908 Devices Expands ZipChip Application in Drug Discovery. Industry-leading Mass Spectrometers Added to Compatibility Roster". Boston, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
» top